Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hemodialysis/инфаркт

Веза се чува у привремену меморију
Страна 1 од 2472 резултати

The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Dialysis patients have an excessive risk of cardiovascular death after myocardial infarction (MI). Underutilization of cardiac therapies may partially explain this risk, but whether patients on maintenance dialysis have differential rates of coronary angiography or revascularization

Statin treatment in dialysis patients after acute myocardial infarction improves overall mortality.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
While statins are widely accepted as a keystone for secondary prevention of cardiovascular disease in the general population, statin treatment in chronic renal failure is still debated. Statins have shown no benefit on cardiovascular outcomes in 4D, AURORA, and SHARP trials conducted in patients on

Association of Syntax Score II with Contrast-induced Nephropathy and Hemodialysis Requirement in Patients with ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE Contrast-induced nephropathy (CIN) is a common complication of primary percutaneous coronary intervention (pPCI) and is associated with high mortality and morbidity and long hospital stay in patients with ST elevation myocardial infarction (STEMI). The Syntax Score (SS) has previously been

Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND The risks of major cardiac events in patients initiating long-term dialysis related to prior coronary disease and various other factors are not well known. METHODS We used United States Renal Data System data to analyse the outcomes of non-fatal myocardial infarction (MI) and cardiac

Red blood cell distribution width as a marker of cerebral infarction in hemodialysis patients.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Red blood cell distribution width (RDW) is a cardiovascular biomarker. We evaluated the association between RDW and cerebral stroke risk in hemodialysis patients. METHODS A cohort of 442 adult patients on hemodialysis was studied. Strokes were defined according to ICD-10 diagnosis codes.

Hemodialysis immediately after acute myocardial infarction.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Acute myocardial infarction (AMI) is common in patients who have end-stage renal disease. However, the prudent interval after AMI until resuming hemodialysis is unknown. Also incidence and severity of intradialytic morbid events during the initial dialysis treatment after AMI have not been

Does timing of dialysis in patients with ESRD and acute myocardial infarcts affect morbidity or mortality?

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE Patients with ESRD have an increased incidence of coronary events with a relatively higher risk for mortality after acute myocardial infarction (AMI). We evaluated whether it is safer to delay dialysis in AMI or if delay poses separate risks. METHODS We conducted a retrospective review of

Infarction of intestine with massive amyloid deposition in two patients on long-term hemodialysis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Two patients undergoing hemodialysis for 19 and 13 yr, respectively, developed intestinal infarction with extensive amyloid deposits in the muscle layer and blood vessels. In 1 patient the deposit reacted positively with antiserum to beta 2-microglobulin by immunohistochemical stain, and therefore

Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Beta-blockers, statins, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs) are standard therapies after myocardial infarction (MI) in the general population. Their use and association with mortality in elderly dialysis patients after MI have not been

PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Myocardial infarction (MI) is a leading cause of death, particularly in high-risk settings such as uraemia, in which it is not yet known to what extent genetic factors contribute to the overall risk of MI. We have prospectively evaluated the effect of plasminogen activator inhibitor-1

Nonocclusive mesenteric infarction in continuous ambulatory peritoneal dialysis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Nonocclusive mesenteric infarction has recently been diagnosed with increasing frequency in dialysis patients. Although most reports have concerned patients on hemodialysis, the condition has also been reported to occur in patients on continuous ambulatory peritoneal dialysis. This report describes

Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND It is has been suggested that dialysis patients have lower mortality rates for pulmonary embolism than the general population, because of platelet dysfunction and bleeding tendency. However, there is limited information whether dialysis is indeed associated with a decreased mortality risk

Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Atherosclerotic cardiovascular disease is the major cause of morbidity and mortality in patients with chronic renal failure undergoing dialysis therapy. Aim of the study was to evaluate whether there is a correlation between a past infection with Chlamydia pneumoniae inducing antibody

Transient visual loss may anticipate occipital infarction from hemodialysis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND The aim of this study was to report on a patient who had occipital infarction from intradialytic hypotension and review the literature on hemodialysis and visual loss. METHODS Neuro-ophthalmologic examination and magnetic resonance imaging (MRI) of the brain were conducted. RESULTS A

A case of cerebral infarction during a hemodialysis procedure successfully treated with recombinant tissue plasminogen activator.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Thrombolytic therapy is an effective treatment for acute ischemic stroke and provides benefits and improvements that lead to better neurological outcomes. However, thrombolytic therapy with recombinant tissue plasminogen activator (r-tPA) in hemodialysis (HD) patients is limited because HD patients
Придружите се нашој
facebook страници

Најкомплетнија база лековитог биља подржана науком

  • Ради на 55 језика
  • Биљни лекови потпомогнути науком
  • Препознавање биљака по слици
  • Интерактивна ГПС мапа - означите биље на локацији (ускоро)
  • Читајте научне публикације повезане са вашом претрагом
  • Претражите лековито биље по њиховим ефектима
  • Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима

Google Play badgeApp Store badge